Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit ... - PR Newswire

Summary

The article discusses Scinai Immunotherapeutics' establishment of a U.S. subsidiary, Scinai Bioservices Inc., to expand its Contract Manufacturing Organization (CMO) services for biotech drug manufacturing. This strategic move aligns with growing U.S. demand for biotech CDMO services amid regulatory changes like the BIOSECURE Act. Tags such as 'Contract manufacturing organization, Drug manufacturing, Laurus Labs, United States' highlight the focus on these biotech manufacturing and service expansions.